Biocryst Pharmaceuticals Inc
BCRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000882796
No open-market purchases or sales by Biocryst Pharmaceuticals Inc insiders were filed in the last 90 days; 319 institutions reported holding it in 13F filings for Q2 2026, worth $2.61B in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Biocryst Pharmaceuticals Inc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 221
- −8 vs. Q1 2022
- Shares held
- 151.9M
- +24.3M (+19.0%) vs. Q1 2022
- Total value
- $1.61B
- −$463.7M (−22.4%) vs. Q1 2022
- New holders
- 43
- 70 more added
- Sold out
- 51
- 62 more reduced
4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 319 | $2.61B |
| Q1 2026 | 303 | $2.37B |
| Q4 2025 | 273 | $1.66B |
| Q3 2025 | 286 | $1.47B |
| Q2 2025 | 294 | $1.77B |
| Q1 2025 | 274 | $1.32B |
| Q4 2024 | 258 | $1.26B |
| Q3 2024 | 257 | $1.32B |
| Q2 2024 | 242 | $1.08B |
| Q1 2024 | 238 | $915.0M |
| Q4 2023 | 236 | $1.06B |
| Q3 2023 | 233 | $1.24B |
| Q2 2023 | 236 | $1.23B |
| Q1 2023 | 242 | $1.42B |
| Q4 2022 | 230 | $1.80B |
| Q3 2022 | 234 | $1.87B |
| Q2 2022 | 221 | $1.61B |
| Q1 2022 | 233 | $2.07B |
| Q4 2021 | 206 | $1.63B |
| Q3 2021 | 197 | $1.48B |
| Q2 2021 | 195 | $1.65B |
| Q1 2021 | 191 | $1.06B |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Biocryst Pharmaceuticals Inc; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Norges Bank | 1,985,365 | $21.0M | 0.01% | +1,189,837+149.6% | Added |
| Two Sigma Advisers, LP | 2,083,412 | $22.0M | 0.06% | +312,400+17.6% | Added |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 2,099,327 | $22.2M | 0.08% | +434,071+26.1% | Added |
| PFM Health Sciences, LP | 2,162,411 | $22.9M | 0.89% | +2,162,411 | New |
| Artisan Partners Limited Partnership | 2,917,209 | $30.9M | 0.05% | +75,804+2.7% | Added |
| Assenagon Asset Management S.A. | 3,177,871 | $33.6M | 0.14% | +3,107,027+4,385.7% | Added |
| Geode Capital Management, LLC | 3,282,157 | $34.7M | 0.01% | +1790.0% | Added |
| Fairmount Funds Management LLC | 3,343,107 | $35.4M | 8.10% | +3,343,107 | New |
| RP Management, LLC | 3,846,154 | $40.7M | 16.31% | 00.0% | Unchanged |
| Morgan Stanley | 4,375,569 | $46.3M | 0.01% | +3,665,522+516.2% | Added |
| Victory Capital Management Inc | 4,564,930 | $48.3M | 0.06% | +1,011,409+28.5% | Added |
| FMR LLC | 5,187,777 | $54.9M | 0.01% | −3,226,681−38.3% | Reduced |
| Fisher Asset Management, LLC | 5,216,829 | $55.2M | 0.04% | +1,230,006+30.9% | Added |
| Pictet Asset Management SA | 6,046,961 | $64.0M | 0.09% | +940,058+18.4% | Added |
| Avoro Capital Advisors LLC | 6,500,000 | $68.8M | 1.36% | +4,625,000+246.7% | Added |
| State Street Corp | 11,004,803 | $116.4M | 0.01% | +3,542,051+47.5% | Added |
| Baker Bros. Advisors LP | 12,710,818 | $134.5M | 0.76% | 00.0% | Unchanged |
| Vanguard Group Inc | 13,810,173 | $146.1M | 0.00% | +603,133+4.6% | Added |
| BlackRock Inc. | 13,987,418 | $148.0M | 0.00% | −114,557−0.8% | Reduced |
| International Biotechnology Trust PLC | 602 | – | – | −56,398−98.9% | Reduced |
| Sofos Investments, Inc. | 22 | – | – | −10−31.3% | Reduced |
| Loomis Sayles & Co L P | 0 | $0 | 0.00% | −2,356,216−100.0% | Sold out |
| Lord, Abbett & Co. LLC | 0 | $0 | 0.00% | −2,318,016−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −1,012,000−100.0% | Sold out |
| Lisanti Capital Growth, LLC | 0 | $0 | 0.00% | −662,644−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −519,050−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −476,978−100.0% | Sold out |
| Granahan Investment Management Inc | 0 | $0 | 0.00% | −469,430−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −303,008−100.0% | Sold out |
| Biondo Investment Advisors, LLC | 0 | $0 | 0.00% | −261,205−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −162,969−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −127,510−100.0% | Sold out |
| Tamarack Advisers, LP | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| Capital Fund Management S.A. | 0 | $0 | 0.00% | −117,505−100.0% | Sold out |
| EAM Global Investors LLC | 0 | $0 | 0.00% | −104,754−100.0% | Sold out |
| Calamos Advisors LLC | 0 | $0 | 0.00% | −103,359−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −92,430−100.0% | Sold out |
| Advisory Research Inc | 0 | $0 | 0.00% | −80,482−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −67,306−100.0% | Sold out |
| Virtue Capital Management, LLC | 0 | $0 | 0.00% | −59,973−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −59,450−100.0% | Sold out |
| First Hawaiian Bank | 0 | $0 | 0.00% | −51,735−100.0% | Sold out |
| Pearl River Capital, LLC | 0 | $0 | 0.00% | −45,155−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −42,400−100.0% | Sold out |
| Level Four Advisory Services, LLC | 0 | $0 | 0.00% | −39,681−100.0% | Sold out |
| Avidian Wealth Solutions, LLC | 0 | $0 | 0.00% | −31,000−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −27,389−100.0% | Sold out |
| Quantitative Investment Management, LLC | 0 | $0 | 0.00% | −21,035−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −20,645−100.0% | Sold out |
| Commerce Bank | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Cetera Advisors LLC | 0 | $0 | 0.00% | −18,155−100.0% | Sold out |
| Parametrica Management Ltd | 0 | $0 | 0.00% | −16,005−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −15,513−100.0% | Sold out |
| Gotham Asset Management, LLC | 0 | $0 | 0.00% | −14,548−100.0% | Sold out |
| CIBC World Markets Inc. | 0 | $0 | 0.00% | −14,500−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −11,495−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −11,172−100.0% | Sold out |
| Quantum Private Wealth, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −7,265−100.0% | Sold out |
| Hanseatic Management Services Inc | 0 | $0 | 0.00% | −5,582−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Neo Ivy Capital Management | 0 | $0 | 0.00% | −466−100.0% | Sold out |
| Jones Financial Companies LLLP | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −348−100.0% | Sold out |
| Evoke Wealth, LLC | 0 | $0 | 0.00% | −227−100.0% | Sold out |
| Future Financial Wealth Managment LLC | 0 | $0 | 0.00% | −180−100.0% | Sold out |
| Tradition Wealth Management, LLC | 0 | $0 | 0.00% | −161−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Iron Horse Wealth Management, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Koshinski Asset Management, Inc. | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Cordant, Inc. | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |
| Golden State Equity Partners | – | – | – | – | Not filed |
| SJS Investment Consulting Inc. | – | – | – | – | Not filed |